Cytonics Corporation

Cytonics is on a mission to disrupt the regenerative medicine field with its proprietary and innovative biologic therapies for osteoarthritis. The company is approaching human clinical trials and is raising capital to complete a Phase 1 study.

Closed

October 15, 2022

science

platform logo

Total raised

updated 423 days ago

$2,965,713

16%

Funding goal

$1.5M- $19M

Minimum ticket

Investors

1456

Regulation

County Flag
C

EQUITY

Share price

$2.3

Pre-money valuation

$46,701,000

Discover our exclusive features for registered users

Understand when and how people have invested in a campaign with our hourly commitments and investor data.

Benefit from AI-powered company descriptions and other important information.

Access financial statements from various sources in one convenient location.

No subscription required - Wixdom is and will remain free to use! Register now to access our industry-leading crowdfunding data.

Sign up for free

Available soon

© 2020-2024 COLLISIO TECHNOLOGIES S.L.